RxDoctor Payments Data

Alan Daniels, MD

Orthopaedic Surgery · East Providence, RINPI 1760642698

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,406,476 of the $1,906,260 with a category attached, or 73.8%. Spineart SA accounts for 65.6% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $678,395, more than ten times the $41,618 reported in 2019. Among orthopaedic surgery clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,906,260in general payments, 2019–2025

Across 587 payments — averaging $3247.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineart SA$1.2M
  • Medtronic$377K
  • Stryker$158K
  • VB Spine LLC$43K
  • Spineart USA Inc$43K
  • Southern Spine, LLC$11K
  • plus $24K from 11 others
$665,139in research payments, 2019–2025

Across 37 payments — averaging $17,977 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$516K
  • Orthofix Medical, Inc.$118K
  • Stryker$31K

What the payments were for

  • Royalty or licence$1,406,47674%
  • Consulting fees$393,58121%
  • Speaking & faculty fees$44,3502%
  • Travel & lodging$25,4541%
  • Food & beverage$28,8992%
  • Charitable contribution$7,5000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,906,260 in reported general payments places this provider in the 95th percentile of 124 orthopaedic surgery providers in Rhode Island.

See all orthopaedic surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$406,683
Medicare patients
340
Services billed
2,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin42$408
Cyclobenzaprine Hcl29$191
Ibuprofen17$162
Oxycodone Hcl14$130
Meloxicam31$117
Tramadol Hcl16$115

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in East Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →